We are your trusted health partner. Local doorstep deliveries is within the hour .We are Licensed and Regulated by the Pharmacist's Council of Nigeria(PCN).Prices displayed here may differ due to inflation.
A sterile, prescription-only injectable solution consisting of human Rho(D) Immune Globulin antibodies, administered via intramuscular (IM) injection to prevent Rh immunization (hemolytic disease of the newborn) in Rh-negative individuals.
RhoGAM contains specialized antibodies directed against the Rho(D) antigen found on the surface of Rh-positive red blood cells. When an Rh-negative mother is exposed to Rh-positive fetal blood cells (which can occur during pregnancy, delivery, or abdominal trauma), her immune system naturally recognizes the foreign D-antigen and creates permanent antibodies against it—a process called Rh isoimmunization.
Once injected into the mother's muscle tissue, RhoGAM works systemically through a targeted immune clearance mechanism:
Passive Antibody Binding: The injected antibodies travel rapidly into the circulation and attach directly to any stray Rh-positive fetal red blood cells that have crossed into the mother’s bloodstream.
Rapid Immune Clearance: By masking the foreign D-antigens and marking the fetal cells for rapid destruction by the mother's spleen before her native immune cells can detect them, RhoGAM completely blocks her body from mounting an active immune response.
Future Pregnancy Protection: Preventing the creation of maternal anti-D antibodies ensures that her immune system will not attack or destroy the red blood cells of an Rh-positive fetus in any subsequent pregnancies, completely eliminating the risk of life-threatening Hemolytic Disease of the Fetus and Newborn (HDFN).
Routine Antenatal Prophylaxis: Administered standardly to Rh-negative pregnant women at 28 weeks of gestation when the unborn child's blood type is known or suspected to be Rh-positive.
Postpartum Prophylaxis: Administered rapidly within 72 hours of delivery if the newborn is confirmed to be Rh-positive.
Obstetric Complication Management: Prevention of maternal sensitization following clinical events that can trigger fetal-maternal bleeding, including miscarriage, ectopic pregnancy, induced abortion, amniocentesis, chorionic villus sampling (CVS), external cephalic version, or significant blunt abdominal trauma during pregnancy.
Transfusion Mismatch Rescue: Treating Rh-negative individuals who have accidentally received mismatched transfusions of Rh-positive red blood cells or blood components.
Intramuscular (IM) Injection Only: RhoGAM must be administered strictly via deep intramuscular injection into a large muscle mass, such as the deltoid muscle of the upper arm.
Note: It must never be injected intravenously (IV). Do not administer RhoGAM to the newborn baby; the injection is intended strictly for the mother.
Rh-negative pregnant or postpartum women who have not already become actively sensitized to the Rho(D) factor (meaning their baseline indirect Coombs antibody screening tests are negative).
Prior Rh Sensitization: Completely ineffective if the mother has already manufactured her own active anti-D antibodies from a previous unmanaged pregnancy exposure. RhoGAM cannot reverse an existing immune sensitization.
Rh-Positive Individuals: Never administered to individuals who are naturally Rh-positive.
Severe IgA Deficiency: Use with extreme caution if you have a documented history of severe immunoglobulin A ($\text{IgA}$) deficiency. RhoGAM contains small amounts of $\text{IgA}$, which can trigger severe, life-threatening allergic reactions (anaphylaxis) in individuals who possess anti-$\text{IgA}$ antibodies.
The 72-Hour Window Law: For postpartum or trauma exposure, RhoGAM must be administered as soon as possible, and strictly within 72 hours of delivery or the bleeding event. If more than 72 hours pass, its clinical effectiveness drops progressively, though it should still be given as a rescue measure.
The Screening Mandate: Before giving the postpartum dose, a maternal blood sample (such as a Kleihauer-Betke test) is standardly performed to measure the exact volume of fetal blood that crossed over. If a massive fetal-maternal hemorrhage occurred during a difficult delivery, your clinician will calculate and administer multiple vials to fully neutralize the exposure.
The Live Vaccine Interaction: Because RhoGAM contains active antibodies, it can interfere with your body's response to live virus vaccines. If you need a live vaccine (such as Rubella or MMR) after delivery, your doctor will check your antibody levels a few months later to ensure the vaccine worked properly.
1.Verify maternal and infant Rh status:Blood Verification.
Confirm via lab documentation that the mother is Rh-negative and has a negative antibody screen, and verify that the newborn baby or transfusion source is confirmed Rh-positive.
2.Bring the prefilled syringe to room temperature:Preparation.
Remove the prefilled syringe from the refrigerator. Inspect the clear liquid inside the barrel to ensure it is colorless and free of solid particles. Let it warm up naturally for 15 minutes before injection.
3.Inject deeply into the upper arm muscle:Deltoid Injection.
Cleanse the skin over the deltoid muscle with an alcohol swab. Insert the needle straight into the muscle at a 90-degree angle and depress the plunger steadily. Withdraw the needle quickly and apply gentle pressure.
4.Observe the patient closely for allergic signs:Safety Monitoring.
Keep the mother under direct clinical observation for at least 20 to 30 minutes following the injection. Monitor for sudden breathing changes, skin hives, or lightheadedness.
Because RhoGAM is a highly purified biological product derived from human plasma, it is generally exceptionally well-tolerated, but it can prompt minor, transient adjustments, including:
Localized pain, mild tenderness, swelling, redness, or a warm sensation directly around the intramuscular injection site in the arm.
A mild, transient increase in body temperature or brief chills shortly after administration.
Infrequent systemic changes, including mild headaches, muscle aches, or brief dizziness.
Do I need a RhoGAM injection with every single pregnancy if I am Rh-negative?
Yes, absolutely. Every single pregnancy carries a fresh risk of fetal-maternal blood crossover. Your body does not maintain permanent protection from a previous RhoGAM injection, as the passive antibodies break down completely after a few months. You must receive the standard dose at 28 weeks and again within 72 hours of delivery for every pregnancy, provided the child is Rh-positive.
What happens if I forget or miss the 72-hour window after giving birth?
If the 72-hour window is missed, contact your obstetrician immediately. While RhoGAM is most effective when delivered within this timeframe, clinical guidelines suggest administering the injection as late as 13 to 28 days post-delivery if a delay occurs, as it may still provide partial protection against sensitization.
How is the safety of RhoGAM managed since it is derived from human plasma?
RhoGAM undergoes an incredibly rigorous, multi-step ultra-filtration and viral inactivation process during manufacturing. This patented clearance system eliminates the risk of transmitting blood-borne viral pathogens (such as HIV, Hepatitis B, and Hepatitis C), ensuring the biological fluid is completely safe for maternal administration.
You can purchase genuine, factory-certified RhoGAM Ultra-Filtered PLUS Injections online through Sanlive Pharmacy & Stores for secure payment and specialized cold-chain delivery directly to your designated hospital, fertility clinic, or home within Lagos, Abuja, and Port Harcourt.
Important Notice: This information is for educational support and tracking purposes only. RhoGAM is a critical biological blood product that must be cross-matched, prepped, and administered strictly by a qualified doctor, obstetrician, or nurse within a registered medical facility.
No reviews yet — be the first!
Log in to write a review.
.jpg)
